Chemed Corporation (CHE) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $537.17 --0%
Financial Fact:
Service revenues and sales: 392.61M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Service revenues and sales: 392.61M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Chemed Corporation (NYSE: CHE) reported Q2 EPS of $4.84, $0.06 better than the analyst estimate of $4.78. Revenue for the quarter came in at $531 million versus the consensus estimate of $538.07 million.
For earnings history and earnings-related data on Chemed Corporation (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
